Bruce & Co
Latest statistics and disclosures from Bruce & Co's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UHAL.B, Merck & Co, ABBV, DUK, XEL, and represent 42.36% of Bruce & Co's stock portfolio.
- Added to shares of these 4 stocks: DAR, VICR, PSNL, Accelerate Diagnostic.
- Reduced shares in these 10 stocks: Paratek cv 4.75% (-$8.4M), PFE (-$7.2M), ALL, ABBV, XEL, T, CMS, NextEra Energy, Valeant Pharmaceuticals Int, UHAL.B.
- Sold out of its position in Paratek cv 4.75%.
- Bruce & Co was a net seller of stock by $-36M.
- Bruce & Co has $287M in assets under management (AUM), dropping by -2.34%.
- Central Index Key (CIK): 0001358331
Tip: Access up to 7 years of quarterly data
Positions held by Bruce & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for Bruce & Co
Bruce & Co holds 37 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Uhaul B Common (UHAL.B) | 13.2 | $38M | -3% | 536k | 70.44 |
|
Merck Common | 8.4 | $24M | 221k | 109.02 |
|
|
Abbvie Common (ABBV) | 7.5 | $21M | -15% | 138k | 154.97 |
|
Duke Energy Common (DUK) | 6.9 | $20M | -4% | 204k | 97.04 |
|
XEL Energy Common (XEL) | 6.4 | $18M | -14% | 293k | 62.79 |
|
CMS Energy Common (CMS) | 6.4 | $18M | -11% | 316k | 58.07 |
|
Nextera Energy Common | 6.2 | $18M | -9% | 294k | 60.74 |
|
Allstate Common (ALL) | 6.2 | $18M | -19% | 127k | 139.98 |
|
Abbott Common (ABT) | 5.8 | $17M | -6% | 150k | 110.07 |
|
At & T Common (T) | 5.6 | $16M | -13% | 961k | 16.78 |
|
Insteel Common (IIIN) | 4.6 | $13M | 343k | 38.29 |
|
|
Pfizer Common (PFE) | 2.7 | $7.7M | -48% | 269k | 28.79 |
|
Avista Common (AVA) | 2.5 | $7.2M | 202k | 35.74 |
|
|
Darling Ingredients Common (DAR) | 2.4 | $7.0M | +100% | 140k | 49.84 |
|
Apple Common (AAPL) | 2.4 | $6.8M | -12% | 35k | 192.53 |
|
Bausch Health Common | 1.8 | $5.2M | -24% | 644k | 8.02 |
|
Uhaul Common (UHAL) | 1.8 | $5.1M | 71k | 71.80 |
|
|
XM Sirius Common (SIRI) | 1.1 | $3.1M | 558k | 5.47 |
|
|
Edap Common (EDAP) | 1.0 | $2.9M | 554k | 5.28 |
|
|
Newmont Common (NEM) | 0.9 | $2.7M | 66k | 41.39 |
|
|
Acorda Theraputics Cv 6.0% (Principal) | 0.9 | $2.4M | 5.0M | 0.49 |
|
|
Supernus Common (SUPN) | 0.8 | $2.4M | 82k | 28.94 |
|
|
Accelerate Diagnostic Cv 5.0% (Principal) | 0.7 | $1.9M | +2% | 3.1M | 0.61 |
|
Kodiak Sciences Common (KOD) | 0.5 | $1.4M | 473k | 3.04 |
|
|
Vicor Common (VICR) | 0.5 | $1.3M | +50% | 30k | 44.94 |
|
Ashland Common | 0.4 | $1.3M | 15k | 84.31 |
|
|
Lava Theraputics Common (LVTX) | 0.4 | $1.2M | 772k | 1.58 |
|
|
Caribu Biosciences Common (CRBU) | 0.4 | $1.1M | 200k | 5.73 |
|
|
908 Devices Common (MASS) | 0.3 | $766k | 68k | 11.22 |
|
|
Mannkind Common (MNKD) | 0.2 | $710k | 195k | 3.64 |
|
|
Viatris Common (VTRS) | 0.2 | $631k | 58k | 10.83 |
|
|
Personalis Common (PSNL) | 0.2 | $630k | +100% | 300k | 2.10 |
|
IGM Bioscience Common (IGMS) | 0.2 | $540k | -45% | 65k | 8.31 |
|
Fate Theraputics Common (FATE) | 0.2 | $535k | -28% | 143k | 3.74 |
|
Organon Common (OGN) | 0.2 | $450k | 31k | 14.42 |
|
|
Rli Common (RLI) | 0.1 | $266k | 2.0k | 133.12 |
|
|
Warner Bros. Discovery Common (WBD) | 0.0 | $121k | -10% | 11k | 11.38 |
|
Past Filings by Bruce & Co
SEC 13F filings are viewable for Bruce & Co going back to 2010
- Bruce & Co 2023 Q4 filed Feb. 12, 2024
- Bruce & Co 2023 Q3 filed Nov. 13, 2023
- Bruce & Co 2023 Q2 filed Aug. 8, 2023
- Bruce & Co 2023 Q1 filed May 12, 2023
- Bruce & Co 2022 Q4 filed Feb. 15, 2023
- Bruce & Co 2022 Q3 filed Nov. 15, 2022
- Bruce & Co 2022 Q2 filed Aug. 9, 2022
- Bruce & Co 2022 Q1 filed May 11, 2022
- Bruce & Co 2021 Q4 filed Feb. 16, 2022
- Bruce & Co 2021 Q3 filed Nov. 12, 2021
- Bruce & Co 2021 Q2 filed Aug. 16, 2021
- Bruce & Co 2021 Q1 filed May 17, 2021
- Bruce & Co 2020 Q4 filed Feb. 16, 2021
- Bruce & Co 2020 Q3 filed Nov. 13, 2020
- Bruce & Co 2020 Q2 filed Aug. 14, 2020
- Bruce & Co 2020 Q1 filed May 15, 2020